Cornerstone Capital Management Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-148,900
| Closed | -$2.37M | – | 1374 |
|
|
2016
Q4 | $2.37M | Sell |
148,900
-56,700
| -28% | -$904K | 0.02% | 693 |
|
|
2016
Q3 | $3.42M | Buy |
205,600
+18,500
| +10% | +$308K | 0.03% | 586 |
|
|
2016
Q2 | $2.09M | Buy |
187,100
+128,700
| +220% | +$1.44M | 0.02% | 716 |
|
|
2016
Q1 | $488K | Buy |
58,400
+47,400
| +431% | +$396K | ﹤0.01% | 1046 |
|
|
2015
Q4 | $102K | Buy |
+11,000
| New | +$102K | ﹤0.01% | 1308 |
|
|
2015
Q3 | – | Sell |
-4,500
| Closed | -$57K | – | 1556 |
|
|
2015
Q2 | $57K | Sell |
4,500
-8,400
| -65% | -$106K | ﹤0.01% | 1348 |
|
|
2015
Q1 | $120K | Buy |
+12,900
| New | +$120K | ﹤0.01% | 1247 |
|
|
2014
Q3 | – | Sell |
-10,400
| Closed | -$168K | – | 1355 |
|
|
2014
Q2 | $168K | Buy |
10,400
+8,500
| +447% | +$137K | ﹤0.01% | 1127 |
|
|
2014
Q1 | $31K | Buy |
+1,900
| New | +$31K | ﹤0.01% | 1265 |
|
|
2013
Q3 | – | Sell |
-28,604
| Closed | -$232K | – | 1352 |
|
|
2013
Q2 | $232K | Buy |
+28,604
| New | +$232K | ﹤0.01% | 1031 |
|